US Telehealth Market

United States Telehealth Market Latest Trends

Virtual care in the United States is increasingly being integrated with longitudinal healthcare delivery instead of being sold solely as an alternative to office appointments. HRSA-supported health centers delivered 17.6 million virtual visits in their latest reported operating year, demonstrating continued institutional use within federally supported primary-care infrastructure. Mental-health care, chronic-condition management, nutrition, primary care, and follow-up services remain particularly suited to remote delivery because these workflows depend heavily on communication, monitoring, medication management, and repeat engagement. Health systems are also deploying virtual nursing, centralized monitoring, and remote clinical collaboration to improve workforce utilization.

Another visible U.S. trend is the convergence of telehealth with artificial intelligence, connected medical devices, patient portals, and navigation technology. Virtual-care companies are adding AI-supported triage, personalized guidance, benefits navigation, provider matching, clinical documentation support, and automated routing while retaining clinician oversight for medical decisions. Remote patient monitoring is also expanding beyond basic collection of blood pressure or weight data toward connected workflows that combine device transmission, alerts, care management, and longitudinal clinical review.

Distribution channels are broadening as retailers, employers, health plans, public programs, and large integrated delivery systems embed virtual care inside existing consumer relationships. Teladoc Health's availability through Walmart's U.S. healthcare platform illustrates how virtual-care suppliers are seeking access through high-traffic consumer ecosystems rather than depending entirely on direct acquisition. This channel shift increases competitive pressure on standalone telehealth applications and strengthens the value of payer eligibility integration, transparent benefit information, and continuity with local provider networks.

United States Telehealth Market Dynamics

The U.S. market is shaped by simultaneous pressure for healthcare access, workforce efficiency, consumer convenience, and regulatory control. Medicare data show that 25% of fee-for-service users received a telehealth service in the latest federally reported annual measure, confirming that virtual care remains embedded in publicly financed healthcare use. Demand is strongest when remote delivery removes travel, scheduling, or specialist-access barriers while remaining integrated with established clinical workflows. Competitive performance increasingly depends on reimbursement compatibility, clinical quality, interoperability, security, and the ability to support hybrid care.

Drivers of Market Growth

High digital connectivity and widespread use of connected consumer devices are supporting routine virtual healthcare access across the United States.

Smartphones have become an important access point for video consultations, secure messaging, appointment management, prescription workflows, patient education, benefits navigation, and remote monitoring applications. Published U.S. market evidence identifies 276.14 million smartphone users, giving providers a large installed base for mobile-first healthcare delivery. This device availability reduces the infrastructure required for basic virtual consultations and enables providers to extend care into homes without creating dedicated physical facilities. It also supports notifications, symptom tracking, digital intake, patient-reported outcomes, and integration with consumer health devices.

For health systems and insurers, widespread mobile access improves the feasibility of population-scale digital programs. Telehealth platforms can connect patients with clinicians, behavioral-health specialists, pharmacists, coaches, and care navigators while maintaining centralized scheduling and records. The same connectivity supports escalation from virtual encounters to physical care when diagnostic testing or procedures are required. This combination of consumer access and provider integration remains a central demand driver for the U.S. Telehealth Market.

Market Restraints

Unequal broadband availability continues to restrict dependable telehealth access for portions of rural and medically underserved U.S. populations.

Telehealth requires sufficient connectivity for reliable audio, video, device transmission, patient authentication, and access to cloud-based clinical systems. Federal health-center research found that 20.32% of households among populations located outside established health-center drive-time access lacked broadband service, illustrating how digital infrastructure gaps can overlap with physical healthcare-access limitations. Poor connectivity can result in interrupted consultations, reduced video quality, delayed device-data transmission, and greater reliance on audio-only care. These conditions weaken the ability of advanced virtual-care models to operate consistently in some communities.

Connectivity limitations also affect provider economics because platforms must maintain alternative workflows for users who cannot reliably participate through video. Vendors may need telephone options, asynchronous messaging, device connectivity support, multilingual technical assistance, and simplified patient onboarding. Rural organizations can face additional implementation constraints involving IT staffing, cybersecurity, local device support, and integration with small-practice systems. Consequently, broadband inequality remains both an access restraint and an operational complexity for U.S. telehealth providers.

Market Opportunities

Federally supported primary-care organizations provide a substantial domestic opportunity for embedded telehealth, remote monitoring, and specialty-access programs.

The United States has a large safety-net healthcare infrastructure serving rural communities, low-income populations, and medically underserved areas. Federal telehealth data indicate that 95% of HRSA-funded health centers used telehealth to provide primary care in the latest published measure. This level of institutional participation creates opportunities for virtual-care platforms, secure communications, remote diagnostic peripherals, specialist networks, patient-engagement software, and connectivity services designed for community healthcare settings.

Telehealth can help these organizations connect patients to specialists that are unavailable locally while reducing travel burdens and maintaining continuity through local clinicians. Opportunity also exists in nutrition services, maternal care, behavioral health, chronic-disease management, remote therapeutic monitoring, and post-discharge follow-up. Vendors able to operate within federally funded healthcare environments must support reimbursement rules, accessibility, privacy protections, and integration with established clinical documentation systems. Technical assistance programs and public investment further strengthen this addressable domestic deployment environment.

Market Challenges

Policy transitions can rapidly alter utilization when reimbursement, eligibility, or prescribing rules change.

U.S. telehealth demand is influenced directly by federal payment decisions and temporary statutory flexibilities. Federal agencies reported a 24% decline in fee-for-service telemedicine visits after a prior Medicare telehealth flexibility lapse, demonstrating how quickly utilization can react when coverage conditions change. This creates planning difficulty for providers that must make staffing, technology, contracting, and network decisions while policy frameworks remain subject to legislative action.

State licensing requirements add another layer because clinicians generally need authority to practice where the patient is located. Telehealth companies serving national populations must therefore manage credentialing, professional licensing, prescribing rules, malpractice considerations, payer contracts, and state-specific operating requirements. Providers must also adapt to changing rules for controlled medications, audio-only encounters, behavioral-health requirements, and eligible originating sites. The challenge is not lack of demand, but maintaining scalable operations across a complex and evolving U.S. regulatory environment.

United States Telehealth Market SWOT Analysis

Strengths

The U.S. market benefits from deep institutional adoption among hospital-owned physician organizations. In the latest physician-practice research, 73.5% of physicians working in hospital-owned practices reported use of patient videoconferencing. This installed clinical familiarity reduces the training and organizational barriers associated with extending virtual services into additional specialties.

A second strength is the country's established healthcare IT ecosystem. Major health systems already operate electronic health records, patient portals, identity systems, digital scheduling, and secure clinical communications that can support telehealth integration. This infrastructure makes it possible to embed remote care into routine clinical workflows rather than maintain disconnected applications.

The third strength is purchaser diversity. Health plans, employers, public programs, hospitals, physician organizations, and consumers all procure or use virtual-care services. This reduces dependence on a single commercial channel and allows suppliers to develop specialized models for different buyer requirements.

The fourth strength is a mature virtual-care provider base. U.S. operators now offer integrated combinations of primary care, urgent care, behavioral health, dermatology, navigation, chronic-condition services, and remote monitoring. That breadth supports cross-referral and increases continuity within digital-care platforms.

Weaknesses

Independent physician practices can face greater adoption friction than large health-system organizations. U.S. physician research found videoconferencing use among private-practice physicians at 58.3%, reflecting a meaningful adoption gap compared with larger institutional settings. Smaller practices may have fewer dedicated IT resources, weaker purchasing leverage, and greater concern regarding workflow disruption.

Another weakness is fragmentation across platforms, provider networks, payers, and electronic records. A patient may receive virtual care through an employer benefit while maintaining primary records with an unrelated health system. Without effective interoperability, this separation can produce incomplete histories and duplicated administrative work.

Patient preferences also constrain universal substitution of physical care. Certain examinations, imaging procedures, laboratory tests, interventions, and diagnostic workflows still require in-person attendance. Telehealth therefore functions most effectively as part of hybrid care rather than as a replacement for the entire clinical pathway.

Digital literacy remains uneven across age groups and patient populations. Complex onboarding, identity verification, application installation, and device pairing can reduce utilization among users with limited technical confidence. Vendors must simplify workflows without weakening privacy or clinical controls.

Opportunities

Behavioral and mental-health delivery remains a major area for domestic virtual-care expansion. HRSA reported that virtual channels represented 37% of mental-health visits across its supported health-center network, showing strong alignment between remote delivery and behavioral-health workflows. Telepsychiatry can extend specialist access, facilitate repeat consultations, and reduce geographic barriers where local clinician capacity is limited.

Remote patient monitoring provides another opportunity because connected devices can extend care management into the home. Blood pressure, glucose, weight, oxygen saturation, and other physiologic measurements can be transmitted into structured clinical workflows. This supports longitudinal management for chronic and acute conditions.

Employer-sponsored virtual care is also evolving from urgent consultation toward primary care, behavioral health, specialty navigation, and cardiometabolic management. Employers value channels that can reduce time away from work while guiding employees toward appropriate in-network care. Integration with health-plan eligibility and benefit information can strengthen adoption.

Artificial intelligence offers further potential when deployed with clinical oversight. AI can assist navigation, summarize information, identify care gaps, streamline documentation, and personalize patient engagement. U.S. providers are increasingly integrating these capabilities directly into telehealth and patient-access platforms.

Threats

Controlled-substance prescribing creates regulatory and compliance exposure for virtual-care providers. Federal agencies reported that 7 million controlled-medication prescriptions were issued through telemedicine without a preceding in-person examination during the cited annual period, illustrating the scale of activity subject to prescribing safeguards. Telehealth organizations must maintain strong identity verification, clinician authorization, prescription monitoring, and fraud controls.

Cybersecurity is another significant threat because virtual care involves protected health information moving across applications, networks, devices, and cloud infrastructure. A security incident can interrupt clinical operations and damage trust among patients, providers, payers, and institutional customers. HIPAA compliance therefore remains a core operating requirement.

Competition is intensifying as traditional health systems, insurers, retailers, technology companies, and dedicated telehealth providers converge on similar care pathways. Standalone consultation providers may face commoditization when health plans or integrated delivery systems bundle virtual access directly into existing offerings. Differentiation increasingly requires measurable care quality and integration.

Reimbursement uncertainty remains an external risk. Federal and state policies can alter eligible services, practitioner requirements, prescribing conditions, or payment structures. Companies with narrow business models are particularly exposed to abrupt policy changes.

United States Telehealth Market Segmentation Analysis

The United States Telehealth Market can be evaluated through product, delivery mode, end use, and disease area because each dimension reflects a distinct purchasing and utilization pattern. Product segmentation identifies the combination of connected hardware, software, and clinical services needed to deliver remote care. Delivery-mode segmentation distinguishes infrastructure architecture, while end-use analysis identifies the economic buyer or care participant. Disease-area segmentation captures differences in clinical suitability, consultation frequency, diagnostic requirements, and specialist availability.

By Product

Services hold the leading position in the U.S. product structure with a verified market share of 47.4%. The segment includes remote patient monitoring, real-time interactions, store-and-forward workflows, and other virtual-care services used by healthcare organizations and patients. Service demand is supported by hospitals and practices that prefer access to clinical networks, implementation support, monitoring operations, and managed digital-care capabilities without building every component internally.

Hardware remains essential where virtual care requires physiologic measurement rather than communication alone. Monitors and medical peripheral devices such as blood pressure meters, glucose meters, weighing scales, pulse oximeters, peak-flow meters, and ECG monitors enable clinicians to obtain structured patient data outside conventional facilities. Software includes standalone and integrated platforms that handle video communication, documentation, scheduling, alerts, data exchange, and clinical workflows. Integrated software is increasingly important as U.S. health systems seek to connect telehealth with electronic records and existing care-management environments.

By Delivery Mode

Web-based telehealth represents the largest verified U.S. delivery-mode segment with a 45.9% share. Web delivery provides relatively straightforward access because patients can enter consultations through browsers without depending entirely on locally installed enterprise applications. Health systems also use web interfaces for virtual visits, remote monitoring dashboards, patient communication, and administrative workflows.

On-premises platforms remain relevant where healthcare organizations prioritize local infrastructure control, established internal systems, or organization-specific security architecture. Cloud-based delivery is gaining strategic importance because it supports centralized updates, scalable computing resources, distributed access, data recovery, and integration across geographically dispersed care teams. U.S. providers are increasingly evaluating cloud architecture as part of wider modernization of electronic records and digital-care systems. The preferred model depends on security policies, integration requirements, enterprise size, procurement strategy, and internal IT capabilities.

By End Use

Providers constitute the leading end-use group in the U.S. Telehealth Market with a verified share of 52.6%. Hospitals, physician groups, health systems, clinics, behavioral-health organizations, and community health providers use telehealth to extend clinician reach and manage workflows across physical and virtual settings. Provider adoption is particularly important because clinical organizations determine how virtual visits connect with records, diagnostic processes, prescriptions, referrals, and follow-up care.

Payers use telehealth as an access, care-management, member-engagement, and network-navigation tool. Health plans can contract with dedicated virtual-care providers or integrate digital access with their existing provider networks. Patients form the third core end-use category and increasingly expect flexible scheduling, mobile access, transparent benefit information, and continuity between virtual and in-person services. Patient demand is strongest when telehealth saves travel or waiting time while still providing access to appropriate licensed clinicians.

By Disease Area

Psychiatry is the leading disease-area segment in the U.S. market with a verified share of 12.4%. Telepsychiatry aligns well with remote delivery because many assessments, medication-management encounters, counseling interactions, and follow-up consultations can be completed through secure communication without physical diagnostic equipment. Domestic shortages of behavioral-health specialists also increase the value of connecting patients with clinicians outside their immediate locality.

Substance-use care similarly benefits from remote follow-up and counseling, although prescribing rules create additional compliance requirements. Radiology supports teleradiology and remote image interpretation, while endocrinology and cardiology increasingly connect telehealth with physiologic monitoring. Dermatology can use synchronous consultation and store-and-forward imaging for appropriate cases. Gastroenterology, neurological medicine, ENT, oncology, dental care, gynecology, general medicine, and other specialties use virtual pathways selectively according to whether the clinical question can be managed without direct physical examination or procedural intervention.

United States Market Analysis

The domestic telehealth environment is increasingly hybrid, integrating digital interactions with physical provider networks rather than operating as a separate healthcare system. HRSA-supported health centers reported virtual encounters representing 13% of their patient visits, showing that telehealth remains a substantial service channel even after normalization of in-person utilization. Buyers now evaluate virtual care through clinical quality, network access, workflow integration, patient experience, security, and total-care coordination.

Hospital systems are deploying virtual workflows to improve access without adding equivalent physical capacity. Insurers and employers use telehealth to offer convenient entry points into primary care, behavioral health, urgent care, and specialist pathways. Technology companies compete by embedding AI, remote monitoring, interoperability, and navigation into digital-care platforms. The resulting market combines clinical services with enterprise technology, connected devices, payer infrastructure, and consumer-facing access channels.

Demand and Adoption

U.S. consumer behavior indicates that virtual care is established but increasingly preference-driven. Consumer research found that 76% of surveyed adults had used virtual care, demonstrating that remote healthcare has reached a broad base of domestic users. Patients are no longer choosing virtual visits simply because physical facilities are restricted; they are evaluating convenience, clinical appropriateness, provider availability, cost, and continuity.

Behavioral health remains well suited to repeat remote engagement, while virtual urgent care addresses common non-emergency conditions. Primary-care models are expanding toward longitudinal relationships with dedicated clinicians rather than isolated episodic encounters. Dermatology and asynchronous care also attract adoption because images and structured symptom information can support remote clinical evaluation in selected cases.

Buyer behavior is changing at the institutional level as well. Health plans and employers increasingly demand integrated platforms capable of directing members toward appropriate care rather than simply generating virtual visits. Hospitals prioritize technology that integrates with clinical records, scheduling, referrals, diagnostics, and existing provider workflows. Consequently, demand is shifting from standalone teleconferencing toward coordinated virtual-care infrastructure.

Regulatory and Policy Environment

Federal policy remains one of the strongest structural influences on the United States Telehealth Market. Current federal guidance extends major Medicare telehealth access flexibilities through December 2027, including home-based access for eligible non-behavioral services and continued participation by eligible Medicare providers. This creates greater operating visibility for healthcare organizations planning virtual-care programs.

Medicare telehealth services remain linked to the Physician Fee Schedule, and the payable service list is reviewed through the federal rulemaking process. Behavioral-health telehealth has distinct provisions, while audio-only care remains available under defined circumstances. Rural Health Clinics and Federally Qualified Health Centers also retain an important role as distant-site providers under current federal extensions.

Controlled-substance prescribing remains separately regulated. Federal telemedicine prescribing flexibilities currently permit eligible practitioners to prescribe controlled medications remotely when statutory and regulatory conditions are satisfied, but providers must comply with federal and state requirements.

HIPAA and related privacy protections govern the handling of protected health information across telehealth platforms. State licensing boards also shape practice because clinician authorization generally follows the patient's location. Successful national platforms therefore require compliance infrastructure capable of supporting federal rules alongside state-specific professional requirements.

Supply Chain and Distribution

The U.S. telehealth supply chain combines software development, cloud infrastructure, connected medical devices, telecommunications, clinical labor, health-plan contracting, implementation services, and technical support. Domestic availability of advanced monitoring platforms allows providers to extend patient observation beyond conventional bedside settings. GE HealthCare, for example, markets U.S. solutions that provide remote access to patient-monitoring information through mobile and web interfaces, illustrating the integration of device data with distributed clinical workflows.

Distribution increasingly occurs through institutional channels rather than traditional medical-equipment sales alone. Health plans contract with virtual-care networks, employers embed digital services into benefits packages, and hospital systems procure enterprise platforms through healthcare IT buying processes. Retail channels are becoming relevant as consumer platforms connect users directly to virtual-care services.

Hardware distribution remains necessary for remote patient monitoring programs involving blood pressure cuffs, glucose devices, scales, pulse oximeters, and other connected peripherals. Vendors must support device provisioning, patient education, connectivity, replacement, and data transmission. Software distribution is primarily cloud or web based, while enterprise deployments often require integration, security review, implementation, and ongoing technical services.

End-User and Industry Adoption

Healthcare providers remain the central operational users of telehealth, but U.S. adoption extends across insurers, employers, public programs, and consumers. MDLIVE states that its virtual-care services are available to 53 million members through domestic health-plan and employer relationships, illustrating the scale that institutional distribution can create. Health plans use virtual care to supplement provider networks and offer members alternatives for urgent, primary, behavioral, dermatology, and chronic-care needs.

Employers use telehealth to improve access for distributed workforces and reduce the logistical burden of routine healthcare appointments. Public-sector organizations also deploy virtual care where geography, workforce deployment, or specialist shortages limit direct access. The U.S. military health system is one example of a large institutional environment using enterprise virtual-care technology.

Patients remain the final adoption decision-makers even when services are employer- or payer-sponsored. Ease of registration, provider availability, wait time, clinical scope, trust, insurance eligibility, prescription handling, and continuity with local care influence utilization. Adoption is strongest when digital care solves a specific access problem without creating additional administrative complexity.

United States Telehealth Market Competitive Landscape

Competition in the U.S. Telehealth Market includes dedicated virtual-care platforms, healthcare technology companies, health systems, insurers, remote-monitoring vendors, and medical-device manufacturers. The market is moving away from competition based only on access to video consultations and toward integrated care models that combine clinical services, digital navigation, data, AI, remote monitoring, and referral coordination. This favors suppliers capable of connecting virtual encounters with broader healthcare ecosystems.

Amwell's continued role in the U.S. Defense Health Agency's Digital First program demonstrates the importance of enterprise-scale deployments; the associated military health system serves 9.6 million beneficiaries. Teladoc Health competes through urgent care, chronic-condition programs, behavioral health, specialist offerings, employer relationships, health-plan contracts, and expanding consumer partnerships. Included Health combines virtual care with navigation and provider-quality matching, while MDLIVE uses its connection with Evernorth to distribute services through health plans and employers.

Oracle, GE HealthCare, Siemens Healthineers, and Medtronic compete from broader healthcare technology and connected-care positions. Their differentiation includes electronic records, patient monitoring, remote clinical access, diagnostic workflows, connected devices, and healthcare data integration. GlobalMed is particularly relevant to government and federal telehealth deployments.

Competitive advantage increasingly depends on clinical breadth, national provider access, interoperability, cybersecurity, consumer experience, payer connectivity, and measurable outcomes. Large purchasers also evaluate vendor stability and the ability to integrate with existing benefit, claims, and clinical infrastructures. Consolidation and strategic partnerships are likely to remain important as buyers seek fewer disconnected digital-health applications.

List of Top United States Telehealth Companies

• GE HealthCare Technologies Inc. (U.S.) — Supplies connected patient-monitoring and remote clinical-access technologies relevant to U.S. hospital and health-system telehealth infrastructure.

• Oracle Corporation (U.S.) — Provides healthcare information systems, cloud-based clinical technology, patient-access solutions, and AI-enabled health-record capabilities for U.S. providers.

• Siemens Healthineers AG (Germany) — Supports U.S. providers with remote imaging, digital healthcare workflows, telepathology concepts, and remote clinical technologies.

• Medtronic plc (Ireland) — Participates through connected medical technologies and remote patient-management ecosystems relevant to digitally enabled care.

• Teladoc Health Inc. (U.S.) — Operates a broad virtual-care platform spanning urgent care, chronic-condition support, behavioral health, specialty care, and integrated-care partnerships.

• American Well Corporation (U.S.) — Supplies enterprise virtual-care technology used by healthcare organizations and major public-sector programs in the United States.

• MDLIVE Inc. (U.S.) — Provides virtual urgent care, primary care, behavioral health, dermatology, chronic-care support, and asynchronous services through U.S. health plans and employers.

• Included Health Inc. (U.S.) — Combines virtual clinical care, healthcare navigation, provider matching, behavioral health, and AI-enabled member support for domestic employers and health purchasers.

• GlobalMed (U.S.) — Provides enterprise and federal-market telehealth infrastructure including virtual-care platforms and connected patient-monitoring capabilities.

Leading Companies by United States Market Share

Reliable public evidence does not disclose directly comparable company-level U.S. telehealth percentage shares for the listed competitors. Teladoc Health and American Well Corporation are therefore identified as two of the strongest companies based on verified domestic telehealth presence rather than invented market-share percentages. Teladoc Health maintains extensive relationships across health plans, employers, consumers, and healthcare providers, while Amwell supports enterprise and government deployments including the U.S. Military Health System.

Both companies compete on platform breadth rather than a single virtual-visit modality. Teladoc is emphasizing connected and longitudinal care, while Amwell focuses heavily on enabling healthcare organizations to operate digital-care programs through enterprise technology. Their U.S. positioning reflects the wider market transition toward integrated virtual-care infrastructure.

United States Investment Trends & Opportunities

Investment in U.S. telehealth increasingly forms part of the wider domestic digital-health funding environment rather than a standalone video-care category. U.S. digital-health startups raised US$14.2 billion in the latest completed annual funding cycle, with capital increasingly directed toward AI-enabled healthcare, consumer engagement, workflow technology, virtual care, and connected health. Funding concentration indicates that investors are prioritizing platforms with clear clinical utility, differentiated technology, strong distribution, and pathways toward sustainable healthcare purchasing relationships.

Public investment also supports telehealth infrastructure and technical assistance. Federal programs fund resource centers that train healthcare organizations, disseminate implementation practices, and support adoption in rural and underserved settings. These initiatives create opportunities for vendors supplying connectivity, cybersecurity, interoperability, connected devices, implementation services, and remote clinical capabilities.

Private opportunities are increasingly concentrated in behavioral health, virtual primary care, cardiometabolic management, remote patient monitoring, women's health, specialist navigation, and AI-assisted patient engagement. Employers represent an attractive channel because virtual services can be incorporated into existing benefits programs. Health plans provide another scalable route through network integration and covered benefits.

Partnerships are becoming a preferred expansion mechanism. Telehealth companies are collaborating with retailers, health plans, connected-device suppliers, employers, and specialist-care platforms rather than building every capability internally. This creates investment opportunities across the supporting ecosystem as the United States Telehealth Market evolves toward coordinated hybrid care.

United States Product Innovation & Development

Product development in the United States is shifting from isolated video visits toward intelligent digital-care environments. Included Health reported that its Provider Connect technology increased connections to top-quartile providers by 92%, illustrating how telehealth platforms are extending beyond consultation into quality-based care navigation. AI tools are increasingly being used to interpret member context, guide patients, identify appropriate clinicians, simplify benefit information, and support coordinated movement between virtual and physical care.

Oracle has expanded U.S. patient-facing digital infrastructure through an AI-powered portal connected with its electronic health-record ecosystem. The platform is designed to help patients review medical information, communicate with providers, and obtain plain-language explanations of clinical information. Such development demonstrates the convergence of telehealth, patient portals, AI, and longitudinal records.

Remote-monitoring innovation is also moving toward less intrusive sensing. GlobalMed's federal-market collaboration with Smart Meter and Neteera integrates contactless ambient sensing with enterprise virtual-care infrastructure, enabling remote monitoring without relying exclusively on patient-operated peripherals.

Teladoc Health is simultaneously developing connected-care models that coordinate multidisciplinary care across virtual settings and local providers. The design direction across the U.S. market is clear: successful telehealth products increasingly combine clinical care, monitoring, data integration, personalization, navigation, and AI while maintaining clinician oversight and regulatory controls.

Recent Developments in the United States Telehealth Market (2023–2026)

• In August 2026, Oracle Corporation made its AI-powered Oracle Health Patient Portal generally available in the U.S. to strengthen patient access to medical records, provider communication, and AI-assisted explanations of clinical information.

• In June 2026, GlobalMed partnered with Smart Meter and Neteera to introduce contactless ambient sensing through its virtual-care platform for the U.S. federal healthcare market.

• In May 2026, Teladoc Health expanded U.S. consumer access by making virtual urgent care, dermatology, and nutrition services available through Walmart's Better Care Services platform.

• In January 2026, Included Health expanded Doctor On Demand virtual primary care through the Blue Cross and Blue Shield of Minnesota provider network.

• In December 2025, Included Health expanded its U.S. platform with an AI-enabled healthcare assistant designed to combine member data with access to nationwide clinical care teams.

• In August 2025, American Well Corporation received an extension through a Leidos-led partnership to continue supporting virtual care for the U.S. Defense Health Agency's Digital First program.

Scope of the United States Telehealth Market Report

The scope of the United States Telehealth Market report is geographically restricted to healthcare demand, technology deployment, competitive activity, regulation, investment, innovation, and end-user behavior inside the United States. The report evaluates product categories consisting of hardware, software, and services while examining on-premises, web-based, and cloud-based delivery architectures. It also analyzes payer, provider, and patient adoption together with telehealth applications across psychiatry, substance-use care, radiology, endocrinology, dermatology, gastroenterology, neurological medicine, ENT, cardiology, oncology, dental care, gynecology, general medicine, and other domestic clinical areas.

Coverage includes federal Medicare telehealth policy, prescribing requirements, privacy obligations, provider licensing considerations, remote-monitoring rules, and public programs affecting domestic deployment. The competitive analysis focuses on companies actively supplying technology, connected monitoring, virtual clinical services, healthcare navigation, enterprise platforms, and government telehealth capabilities in the country.

The report also examines consumer demand, physician adoption, hospital workflows, payer distribution, employer-sponsored services, and public-sector use. Supply-chain coverage includes software delivery, cloud infrastructure, connected medical peripherals, clinical labor, technical implementation, and distribution through healthcare organizations and benefit programs.

Investment and innovation analysis covers AI-enabled care delivery, remote patient monitoring, patient portals, virtual primary care, behavioral health, navigation, specialist access, and hybrid-care models. The report does not substitute global or other-country statistics for unavailable U.S. evidence and treats qualitative domestic analysis as preferable where verified country-specific numerical data are not publicly established.